Kimberly-Clark (NASDAQ:KMB) Price Target Raised to $110.00

Kimberly-Clark (NASDAQ:KMB) had its price target increased by BNP Paribas Exane from $101.00 to $110.00 in a report published on Friday morning,Benzinga reports. BNP Paribas Exane currently has a neutral rating on the stock.

Several other equities research analysts have also recently commented on KMB. Weiss Ratings raised shares of Kimberly-Clark from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, July 28th. Wells Fargo & Company reduced their price objective on shares of Kimberly-Clark from $105.00 to $100.00 and set an “equal weight” rating for the company in a research note on Monday, October 5th. TD Cowen decreased their price objective on Kimberly-Clark from $104.00 to $97.00 and set a “hold” rating for the company in a report on Tuesday, October 13th. Bank of America lowered their target price on Kimberly-Clark from $122.00 to $120.00 and set a “buy” rating on the stock in a research report on Friday, September 25th. Finally, Seaport Research Partners raised Kimberly-Clark to a “buy” rating in a research report on Tuesday, August 4th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, eleven have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $116.50.

Kimberly-Clark Price Performance

NASDAQ KMB opened at $105.57 on Friday. The firm’s 50 day moving average is $102.77 and its 200-day moving average is $102.65. The company has a quick ratio of 0.69, a current ratio of 0.91 and a debt-to-equity ratio of 3.45. The company has a market capitalization of $35.11 billion, a PE ratio of 17.95, a price-to-earnings-growth ratio of 5.41 and a beta of 0.25. Kimberly-Clark has a 12-month low of $92.42 and a 12-month high of $123.09.

Kimberly-Clark (NASDAQ:KMB) last announced its quarterly earnings data on Tuesday, August 4th. The company reported $1.80 EPS for the quarter, missing analysts’ consensus estimates of $2.01 by ($0.21). Kimberly-Clark had a return on equity of 143.92% and a net margin of 11.79%. The business had revenue of $4.19 billion during the quarter, compared to the consensus estimate of $4.22 billion. During the same period in the prior year, the firm earned $1.92 EPS. The business’s revenue for the quarter was up .6% compared to the same quarter last year. Equities research analysts anticipate that Kimberly-Clark will post 7.33 earnings per share for the current fiscal year.

Kimberly-Clark Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, October 2nd. Shareholders of record on Friday, September 4th were paid a $1.28 dividend. The ex-dividend date was Friday, September 4th. This represents a $5.12 dividend on an annualized basis and a yield of 4.8%. Kimberly-Clark’s dividend payout ratio (DPR) is currently 87.07%.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of KMB. Ancora Advisors LLC acquired a new stake in Kimberly-Clark in the 2nd quarter valued at about $32,000. Edmond DE Rothschild Holding S.A. acquired a new stake in shares of Kimberly-Clark in the second quarter valued at approximately $32,000. Clearstead Trust LLC acquired a new stake in shares of Kimberly-Clark in the second quarter valued at approximately $33,000. Markowski Investments acquired a new stake in shares of Kimberly-Clark in the second quarter valued at approximately $36,000. Finally, Avalon Trust Co bought a new position in shares of Kimberly-Clark during the 2nd quarter worth approximately $37,000. Institutional investors own 76.29% of the company’s stock.

Kimberly-Clark News Summary

Here are the key news stories impacting Kimberly-Clark this week:

• Positive Sentiment: Preliminary earnings beat expectations: Kimberly-Clark expects third-quarter adjusted EPS of $1.70, ahead of the $1.58 FactSet consensus. The result was achieved despite lower sales, supporting the view that cost controls and operational improvements are helping protect profitability. Reuters preliminary results article
• Positive Sentiment: 2026 outlook reaffirmed: Management maintained its full-year financial outlook, including organic sales growth expected to be approximately 100 basis points below weighted-average category growth. The absence of a guidance reduction appears to have reassured investors following the weaker sales environment. Kimberly-Clark preliminary results release
• Positive Sentiment: Price target increased: BNP Paribas Exane raised its KMB target from $101 to $110 while maintaining a neutral rating. The target implies modest upside from the current trading level, providing some valuation support but not signaling strong conviction. Benzinga price target report
• Neutral Sentiment: China-related legal issue: Reports indicate China cleared claims involving formamide, potentially reducing a regulatory and litigation overhang. However, the broader commercial impact of the controversy remains uncertain. Reuters China claims article
• Negative Sentiment: Sales and dividend concerns persist: Kimberly-Clark forecast a third-quarter sales decline following a social-media backlash in China. Separate coverage warned that the company’s long dividend-growth streak is under pressure as profits shrink, despite free cash flow still covering payouts. Wall Street Journal sales outlook article

Kimberly-Clark Company Profile

Kimberly-Clark Corporation (NASDAQ:KMB) is a global consumer products company that develops and markets personal care, tissue and professional hygiene products. Its portfolio includes products for babies and children, feminine care, adult care, family care and workplace hygiene.

The company’s well-known brands include Huggies diapers and wipes, Kleenex facial tissue, Cottonelle bathroom tissue, Scott toilet paper and paper towels, Kotex feminine care products, and Depend, Poise and GoodNites products.